Crinetics Pharmaceuticals (CRNX) Q4 2024 Earnings

Nov 12Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.96
-0.91
-0.86
-0.81

Details

Expected EPS
-0.910672
Actual EPS
-0.96
Surprise EPS
-0.05
Surprise Percent
-5.42%

Description

⁨Crinetics Pharmaceuticals⁩ (⁦CRNX⁩) has reported earnings of ⁦-0.96⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts